These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 12527)

  • 1. Single and repeated administration of neuroleptic drugs to rats: effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-Dopa.
    Heal DJ; Green AR; Boullin DJ; Grahame-Smith DG
    Psychopharmacology (Berl); 1976 Sep; 49(3):287-300. PubMed ID: 12527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic drugs block both the hyperactivity and the increase in caudate nucleus cyclic AMP concentration produced by the administration of tranylcypromine and L-dopa to rats.
    Heal DJ; Green AR; Bloomfield MR; Grahame-Smith DG
    Psychopharmacology (Berl); 1978 Apr; 57(2):193-7. PubMed ID: 26101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated chlorpromazine administration increases a behavioural response of rats to 5-hydroxytryptamine receptor stimulation.
    Green AR
    Br J Pharmacol; 1977 Feb; 59(2):367-71. PubMed ID: 264797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs.
    Evans JP; Grahame-Smith DG; Green AR; Tordoff AF
    Br J Pharmacol; 1976 Feb; 56(2):193-9. PubMed ID: 3248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.
    Deakin JF; Green AR
    Br J Pharmacol; 1978 Oct; 64(2):201-9. PubMed ID: 708990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence concerning the involvement of 5-hydroxytryptamine in the locomotor activity produced by amphetamine or tranylcypromine plus L-DOPA.
    Green AR; Kelly PH
    Br J Pharmacol; 1976 May; 57(1):141-7. PubMed ID: 1276533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR; Youdim MB
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-Adrenoceptor antagonists inhibit the behavioural responses of rats to increased brain 5-hydroxytryptamine.
    Costain DW; Green AR
    Br J Pharmacol; 1978 Oct; 64(2):193-200. PubMed ID: 30503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated exposure of rats to the convulsant agent flurothyl enhances 5-hydroxytryptamine- and dopamine-mediated behavioural responses.
    Green AR
    Br J Pharmacol; 1978 Mar; 62(3):325-31. PubMed ID: 638311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of opiates in striatal D-1 dopamine receptor supersensitivity induced by chronic L-dopa treatment.
    Groppetti A; Ceresoli G; Mandelli V; Parenti M
    J Pharmacol Exp Ther; 1990 Jun; 253(3):950-6. PubMed ID: 2162953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurochemical and behavioral effects of the novel cholinesterase-monoamine oxidase inhibitor, ladostigil, in response to L-dopa and L-tryptophan, in rats.
    Sagi Y; Driguès N; Youdim MB
    Br J Pharmacol; 2005 Oct; 146(4):553-60. PubMed ID: 16086033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of butaclamol, a new neuroleptic, on serotoninergic mechanisms.
    Pugsley TA; Lippmann W
    J Pharm Pharmacol; 1977 Mar; 29(3):135-8. PubMed ID: 15075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of brain GABA concentrations with amino-oxyacetic acid; effect on the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats.
    Green AR; Tordoff AF; Bloomfield MR
    J Neural Transm; 1976; 39(1-2):103-12. PubMed ID: 988113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioural and biochemical changes following chronic administration of L-dopa to rats.
    Pycock C; Dawbarn D; O'Shaughnessy C
    Eur J Pharmacol; 1982 Apr; 79(3-4):201-15. PubMed ID: 7201400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine modulates the dopaminergic function in the nigro-striatal system by interacting with striatal dopamine dependent adenylate cyclase.
    Abbracchio MP; Colombo F; Di Luca M; Zaratin P; Cattabeni F
    Pharmacol Res Commun; 1987 Apr; 19(4):275-86. PubMed ID: 2889222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.
    Hall MD; Cooper DR; Fleminger S; Rupniak NM; Jenner P; Marsden CD
    Neuropharmacology; 1984 May; 23(5):545-53. PubMed ID: 6539859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration.
    Clow A; Theodorou A; Jenner P; Marsden CD
    Eur J Pharmacol; 1980 May; 63(2-3):145-57. PubMed ID: 6103814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contrasting actions of TRH and cycloheximide in altering the effects of centrally acting drugs: evidence for the non-involvement of dopamine sensitive adenylate cyclase.
    Green AR; Heal DJ; Grahame-Smith DG; Kelly PH
    Neuropharmacology; 1976 Oct; 15(10):591-9. PubMed ID: 825788
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemical alterations of dopamine receptor responses following chronic L-dopa therapy.
    Wilner KD; Butler IJ; Seifert WE; Clement-Cormier YC
    Biochem Pharmacol; 1980 Mar; 29(5):701-6. PubMed ID: 20227943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.